资讯

Medical Dialogues4 分钟
GSK blood cancer drug Blenrep faces USFDA scrutiny over vision issues
GSK's blood cancer drug, Blenrep, is under the U.S. Food and Drug Administration (USFDA) spotlight, as staff reviewers raised ...
Medical Dialogues59 分钟
NBE opens applications for accreditation to Post MBBS Diploma courses July-November cycle ...
The National Board of Examination in Medical Sciences (NBEMS) has invited applications from Hospitals/Medical ...